Showing results (31-40 of 80) with videos related to
Sort By:
Pageof 8
Journal of the American Chemical Society|July 13, 2011
Aryl C-H amination by diruthenium nitrides in the solid state and in solution at room temperature: experimental and computational study of the reaction mechanismAmanda Kae Musch Long, George H Timmer, József S Pap, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2008
Modeling the cost effectiveness of secondary febrile neutropenia prophylaxis during standard-dose chemotherapyJohanna N H Timmer-Bonte, Eddy M M Adang, Evelien Termeer, et al.International Journal of Cancer|December 15, 1987
Influence of docosahexaenoic acid in vitro on intracellular adriamycin concentration in lymphocytes and human adriamycin-sensitive and -resistant small-cell lung cancer cell lines, and on cytotoxicity in the tumor cell linesJ G Zijlstra, E G de Vries, F A Muskiet, et al.Patient Education and Counseling|August 21, 2022
How is complementary medicine discussed in oncology? Observing real-life communication between clinicians and patients with advanced cancerMarit D C Mentink, Liesbeth M van Vliet, Johanna Anja N H Timmer-Bonte, et al.Cancer Research|December 1, 1993
cis-diamminedichloroplatinum(ii) resistance in vitro and in vivo in human embryonal carcinoma cellsH Timmer-Bosscha, A Timmer, C Meijer, et al.Cancer Research|August 1, 1989
Resistance mechanisms in three human small cell lung cancer cell lines established from one patient during clinical follow-upE G de Vries, C Meijer, H Timmer-Bosscha, et al.Cancer Research|October 15, 1994
Effects of amiodarone, cyclosporin A, and PSC 833 on the cytotoxicity of mitoxantrone, doxorubicin, and vincristine in non-P-glycoprotein human small cell lung cancer cell linesW T van der Graaf, E G de Vries, H Timmer-Bosscha, et al.International Journal of Cancer|September 30, 1993
Enhancement of cisplatin and etoposide cytotoxicity after all-trans retinoic-acid-induced cellular differentiation of a murine embryonal carcinoma cell lineH J Guchelaar, H Timmer-Bosscha, A Dam-Meiring, et al.British Journal of Cancer|November 4, 2010
A phase I dose-escalation study to evaluate safety and tolerability of sorafenib combined with sirolimus in patients with advanced solid cancerI M E Desar, J N H Timmer-Bonte, D M Burger, et al.International Journal of Cancer|November 14, 1997
Mechanisms for high methoxymorpholino doxorubicin cytotoxicity in doxorubicin-resistant tumor cell linesM Bakker, J Renes, A Groenhuijzen, et al.Pageof 8